News Snapshot:
Alibaba leads Series D for China cancer test kit business Guangzhou-based Creative Biosciences, which manufacturers kits that test for colon cancer, has raised a RMB560 million ($88 million) Series D led by Alibaba Group. Other investors include Huaxing Growth Capital, Co-Stone Asset Management, ABC International, Henglu Asset Management. Existing backer IDG Capital re-upped. Founded in 2015, CreativeBio specializes... Latest News [ADIA to lead pre-IPO round for Indonesia's GoTo] Abu Dhabi Investment Authority (ADIA) has committed $400 million to Indonesia super app GoTo as the lead investor in a funding round ahead of the company’s much-anticipated IPO. [India's Cred raises $251m...
